Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 Q2- Text added to 2016 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
argument, BioPharma, Cadilla, categorize, community, CTI, expedient, hierarchy, inception, investee, Ireland, Labour, living, Los, Lysomal, machinery, Ministry, Mochida, Opthalmology, pacritnib, readily, redeemed, SAIIDAC, Stipulation, sum, trihydrate, unsecured, view, voluntary
Removed:
AbbVie, absence, absorbed, achieve, ADDERALL, adenoviral, ADHD, administered, adolescent, aged, Alagille, AMR, analyze, anticipation, ArmaGen, arylsulfatase, assessed, Ataxia, bacterial, birth, blood, body, brain, budesonide, central, characterized, children, chronic, circulating, clarity, CMV, CNS, coat, commonly, companiestotaling, concept, conduct, constipation, coverage, covered, CTN, damage, DED, deemed, deliver, demonstrated, difficult, difficulty, disruption, distributed, dose, dosing, EBT, EMA, enforce, enrolling, entry, enzyme, EoE, ERT, escalation, establish, established, experienced, FA, face, fail, familial, feedback, file, fluid, formulation, found, frequently, Friedreich, fulfilling, GI, globally, healthy, highest, Hunter, impose, increasingly, IND, infantile, infection, ingredient, initiate, initiated, innovation, intended, intrahepatic, intrathecally, INTUNIV, large, LDX, letter, locally, Lysosomal, maribavir, mediated, meeting, met, MLD, MPS, NASH, NATPAR, natural, NMO, OBS, ocular, operational, optimal, path, Pennsylvania, PENTASA, PFIC, pink, pipeline, planning, PMDA, predominately, premature, prevention, profile, progressive, proof, prophylactic, protocol, prucalopride, pursuing, rapidly, rASA, reach, regularly, relief, REPLAGAL, RESOLOR, response, resubmission, resubmitted, revealed, reviewing, routine, safe, safety, scope, secondary, sell, sequential, serum, Shionogi, showed, similar, slower, small, somatic, source, stocking, successfully, surface, suspension, temporarily, timely, tolerability, tolerated, top, transplant, treat, trend, underway, update, VPRIV, week, weight, XR
Valuein 2016 Q2 filing- Value in 2016 Q3 filing
Original filings
Filing view